Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 4Unknown 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 3Plasma cell 2Genitourinary 1

Conditions

Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Prostatic Neoplasms 1Lymphoma, Follicular 1Hodgkin Disease 1Chronic Pain 1Acute Pain 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × Meloxicam × Clear all
NCT02078102 2021-02-21

A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

Indiana University

Phase 2 Completed
38 enrolled 15 charts
LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT01789216 2021-02-03

PAIN

Major Extremity Trauma Research Consortium

Phase 3 Completed
450 enrolled
Lymphoid

Lymphoma, Follicular, Chronic Pain, Acute Pain

NCT02003625 2020-05-18

Meloxicam vs Placebo for Mobilization

Massachusetts General Hospital

Phase 2 Completed
31 enrolled 10 charts
LymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT00152919 2010-08-13

Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy

University Health Network, Toronto

Phase 3 Completed
100 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡